Usana Health Sciences Inc Down 18.46% To $45.20 After Earnings Miss

Usana Health Sciences Inc (USNA) said after close Tuesday that it earned $0.59 per share in quarter three 2023.

On the revenue line, the company reported $213.4 million, missing estimates by $7 million.

In the same quarter a year ago, the company earned $0.78 per share on revenue of $233.3 million.

The stock is down 18.46% to $45.20 after the report.

Usana Health Sciences Inc's profit margins took a hit as earnings fell at a faster pace than revenues.

Wall Street Analysts had an average rating of Buy on the stock prior to the report.

InvestorsObserver gives the stock a Bearish Sentiment score at the moment based on recent trading.

Prior to the report, InvestorsObserver gave the stock an overall score of 50. Meanwhile, the average Wall Street analyst rated the stock a Buy.

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe, with the majority of its revenue generated from markets outside the United States.